ライフサイエンスコーパス: women

1 untries like the United States (1.69 per 100 women).

2 pared to the referent group (Latina/Hispanic women).

3 an age at baseline = 57.5 +/- 5.9 years, 58% women).

4 with low CHA(2)DS(2)-VASc score (0/1 for men/women).

5 73 +/- 8 years, and 52% of participants were women.

6 ared to provide quality care for transgender women.

7 AAA in a large, ethnically diverse cohort of women.

8 ally important benefits for BMD in lactating women.

9 27% at baseline, 35% at the follow-up visit) women.

10 ion of opacities was more common in men than women.

11 The mean age was 46+/-18 years; 55% were women.

12 uring pregnancy, especially for the youngest women.

13 nown cause, usually observed in young, obese women.

14 than that from C-cigs (32%) in both men and women.

15 cer-related deaths (after lung cancer) among women.

16 rdial infarction, particularly among younger women.

17 same indications and combinations offered to women.

18 elated clinical indicators among transgender women.

19 h a high prevalence of unvaccinated pregnant women.

20 ally transmitted C. trachomatis infection in women.

21 HIV) imparts increased heart failure risk to women.

22 1.5% of women and reconstruction in 36.5% of women.

23 n HIV-negative women but not in HIV-positive women.

24 italized, enter intensive care, and die than women.

25 ased risk of incident atherosclerotic CVD in women.

26 Their mean age was 54 years, and 58% were women.

27 firearm and by other methods) among men and women.

28 (BC) is one of the most prevalent cancers in women.

29 opsy samples were obtained from all enrolled women.

30 ong black men and women versus white men and women.

31 -40.1) among men and 22.1% (10.4-31.3) among women.

32 breast cancer among pre- and postmenopausal women.

33 in eight postmenopausal and 25 premenopausal women.

34 r screening in HIV+ and at-risk HIV-negative women.

35 [95% CI 0.66-0.97]; p=0.007), node-positive women (0.76 [0.64-0.91]; p=0.006), and those with a como

36 , 0.64; age 25 to 30 years, 0.65; men, 1.04; women, 0.36; Blacks, 0.90; Whites, 0.50; up to/through h

37 Among Swedish girls and women 10 to 30 years old, quadrivalent HPV vaccination w

38 zed (mean [SD] age, 46 [13] years; 109 [72%] women), 115 (76%) completed the trial.

39 This study included 185 women (128 with longstanding HIV infection, 88% under an

40 Of the 172 pregnancies recorded in these women, 147 (85%, 104 livebirths and 43 spontaneous or el

41 326 adolescents (15-19 years) and 696 young women (20-24 years), 31.7% (95% confidence interval [CI]

42 re randomized (mean age, 68 years; 181 [55%] women), 320 (97%) were included in the primary outcome a

43 3891 participants (mean age 65 +/- 11 y; 55% women; 35% nonwhite), there were 858 incident CVD events

44 ge was 48 (19) years and 25 939 (50.1%) were women; 43.2% were non-Hispanic White adults; 21.6%, non-

45 eloped LVSD more frequently and earlier than women (45+/-14 versus 49+/-16 years, respectively; P=0.0

46 In all, 71 women (5.3%) were LTFU at 3 years: 0.8% in Nigeria, 2.2%

47 We studied women 50 years of age or older who were receiving bispho

48 In the group of 547 women, 593 focal lesions were diagnosed.

49 ars]; body mass index, 32.7 [5.7]; and 74.2% women), 600 were included in the per-protocol population

50 recorded while 29 adult native speakers (22 women, 7 men) listened to naturally spoken Dutch sentenc

51 tients (mean [SD] age, 62.5 [9.0] years; 35% women; 70% with diabetes; median low-density lipoprotein

52 men (7202 with interquartile range 3619) and women (7260 with interquartile range 3068; P=0.52).

53 In 2016, the RWHAP served 6,534 transgender women (79.8% retained in care, 79.0% virally suppressed)

54 79.0% virally suppressed), 143,173 cisgender women (83.7% retained in care, 84.0% virally suppressed)

55 Among postpartum women, 89% were extubated, 89% recovered, and 84% were d

56 and influenza-associated ARFI among pregnant women, administrative and electronic health record data

57 g cancer-related cause of disease burden for women, affecting one in 20 globally and as many as one i

58 rol that occurs in some chronically infected women after childbirth.

59 nal Inpatient Sample was queried to identify women age >=18 years in the United States with pregnancy

60 lts from a secondary data analysis for 1,022 women aged 15-24 who reported ever having sex: 326 adole

61 Eligible participants were women aged 18 years or older with International Federati

62 t women category, compared with adequate GWG women aged 20-29 years did, those older than 20 years wi

63 We recruited 1121 women aged 30-65 years, 586 of whom were HIV-negative an

64 social function-in a sample of 5,018 men and women aged 64.44 (SD 8.49) y on average at baseline.

65 In women aged 70 to 74 years, the estimated difference in 8

66 ncluded racially/ethnically diverse pregnant women (aged 20-45 years-33% primiparous, 37% biparous, 3

67 ot associated with differentiated TC risk in women, although our study raises the possibility that hi

68 We enrolled 351 pregnant women and 109 controls with epilepsy.

69 This study analyzed data for 171,897 women and 167,993 men age 21 years or older with health

70 A total of 102 patients (63 women and 39 men) had vestibulocochlear involvement.

71 m patients with IBS with diarrhea (IBS-D; 18 women and 5 men; aged 28-60 years), healthy individuals

72 11 women and 9 men, for a total of 20 participants, were in

73 y limitations include underrepresentation of women and a lack of detailed information on social deter

74 risk-enhancing factors that are specific to women and are associated with an increased risk of incid

75 Vitamin B-12 and folate deficiencies in women and children have important public health implicat

76 or adverse imaging outcomes, including young women and children.

77 ssociated with increased alcohol drinking by women and experimentally in rodents.

78 ciated with increased likelihood of HSV-2 in women and HSV-2 in male partners.

79 ond leading cause of cancer-related death in women and is a complex disease with high intratumoral an

80 CAD predominantly occurs in relatively young women and is an important cause of myocardial infarction

81 Sexually active unvaccinated women and men aged 16 to 25 years old were recruited fro

82 s and levels of occupational exposures among women and men and can affect prevalence of occupational

83 orosis Foundation guidelines, postmenopausal women and men at least 50 y old with osteopenic BMD warr

84 Women and men were followed up for recurrent MI, recurre

85 Incidence was higher in women and men with OSA (17.2 and 40.8 per 100,000).

86 erval: 1.05, 1.16) and 1.15 (1.10, 1.19) for women and men, respectively.

87 In analyses limited to women and MSW, controlling for HIV status, women display

88 opinion leaders and prenatal counseling for women and partners, although clinical audits, financial

89 ith valsartan alone, consistently in men and women and patients with left ventricular ejection fracti

90 nts were placed for augmentation in 61.5% of women and reconstruction in 36.5% of women.

91 the expected length of time in education for women and the three outcomes: sexual activity, demand fo

92 e urgently needed to better protect pregnant women and their newborns.

93 nd the highest prevalence of constipation in women and young adults (19.7 and 23.5%, respectively).

94 ded 112 fresh frozen (FF, median age 69, 44% women) and 163 formalin-fixed paraffin-embedded (FFPE, m

95 3%, among whom 71.6% were children and 46.5% women) and 20,357 local residents (29.7%, 88.5% children

96 bia (from 90% in white women to 56% in Black women) and in South Africa (from 76% in mixed-race women

97 peripheral AVM (mean age, 40 y; 4 men and 6 women) and scheduled for endovascular embolization treat

98 greater in LMICs in South Asia (3.06 per 100 women) and Sub-Saharan Africa (2.76 per 100 women), comp

99 from 76% in mixed-race women to 59% in Black women), and between different countries (44-47% in Ugand

100 Among those who received LVADs, women (aOR, 1.78 [1.38-2.30]), patients of unknown race

101 It is critical to ensure transgender women are aware of and have accurate information about P

102 ere COVID-19 in adults, but data in pregnant women are limited.

103 ral and behavioral interventions that target women are required to bolster the efficacy of OAT in pre

104 OVID-19 is increasing, many exclude pregnant women as participants or do not address pregnancy.

105 f our data, and our defining sexually active women as those who have ever had sex.

106 aternity hospitals and enrolling nulliparous women at 19-21 weeks.

107 Postmenopausal women at increased risk of developing breast cancer were

108 breast US were retrospectively identified in women at two hospitals (a large tertiary care academic h

109 We obtained blood samples from 185 young women (average age 21.2) in two cohorts and tested the e

110 nation program was introduced in England for women between 28 and 32 weeks of pregnancy.

111 Forty-one overweight men and women (BMI: 27-35 kg/m2; aged 40-70 y) completed the stu

112 ared between unvaccinated and HPV-vaccinated women born 1994-2005.

113 h persistent hrHPV infection in HIV-negative women but not in HIV-positive women.

114 ever, no trials have studied whether or when women can safely stop screening mammography.

115 Among normal weight women category, compared with adequate GWG women aged 20

116 istorical controls comprised of 17 cisgender women (CGW) and 15 CGM.

117 om both symptomatic and asymptomatic men and women collected at geographically diverse sites across t

118 BDE-100 and BDE-153 among non-Hispanic Black women compared to the referent group (Latina/Hispanic wo

119 in urban areas compared with rural areas, in women compared with men, and in newborn babies compared

120 women) and Sub-Saharan Africa (2.76 per 100 women), compared with high-income countries like the Uni

121 east Cancer Study is a prospective cohort of women diagnosed with breast cancer at age <= 40 years an

122 Women diagnosed with EC or atypical hyperplasia (AH) wer

123 All women diagnosed with epithelial ovarian cancer should ha

124 Purpose To determine outcomes of women discussed at consensus meetings during a 5-year pe

125 o women and MSW, controlling for HIV status, women displayed increased alpha-diversity compared with

126 When given to all men and women, DTG-based ART could reduce the level of NNRTI PDR

127 patients with SSc (median age, 57 years; 167 women) evaluated between January 2009 and October 2017.

128 postdose 2 GMCs in previously GBS-vaccinated women exceeded postdose 1 GMCs in previously non-GBS-vac

129 6 to evaluate perinatal outcomes in pregnant women exposed to omalizumab and their infants.

130 scordant couples, adolescent girls and young women, female sex workers, and men who have sex with men

131 jealousy (sexual or emotional) that men and women find most upsetting, rather than on how jealous re

132 ically confirmed residual tumor in 37 of 208 women [FNR, 17.8%; 95% confidence interval (CI), 12.8-23

133 urses' Health Study (NHS; 1980-2012), 89,636 women from the NHS II (1991-2017), and 41,412 men from t

134 rses' Health Study (NHS) (1984-2016), 91,656 women from the NHSII (1991-2015), and 43,911 men from th

135 We prospectively followed 74,578 women from the Nurses' Health Study (NHS) (1984-2016), 9

136 We followed 82,750 women from the Nurses' Health Study (NHS; 1980-2012), 89

137 en throughout pregnancy, could predict which women go on to deliver preterm.

138 old compared to women of the same age, while women >=50 years old had a mortality rate similar to tha

139 dose 1 GMCs in previously non-GBS-vaccinated women (>=7-fold).

140 Over a mean follow-up of 30 months, women had a lower risk of MACE (9.5% vs. 11.2%; adjusted

141 Women had a peculiar biventricular adaptation, with high

142 696 (98%) of 711 women had available data for the primary outcome.

143 Women have been at the forefront of tremendous achieveme

144 as -1.0 (95% CI, -2.3 to 0.1) death per 1000 women (hazard ratio, 0.78 [CI, 0.63 to 0.95]) (a negativ

145 lyzed from retrospective cohorts of pregnant women hospitalized with ARFI who had testing for influen

146 years longer life for men and 7.6 years for women; however, not all lifestyle risk factors equally c

147 le, this benefit persisted for node-negative women (HR 0.80 [95% CI 0.66-0.97]; p=0.007), node-positi

148 Barriers to authorship and representation of women in HF guidelines and HF trial leadership need to b

149 for energy to thermoregulate compared to the women in Ice Maiden.

150 rease in deaths were similar between men and women in most countries.

151 bout scientific progress and the progress of women in our field, we review ongoing challenges and dis

152 -eclampsia in the PreCARE cohort of pregnant women in Paris (n = 9,579).

153 in maternal pre-pregnancy hypertension among women in rural and urban areas in 2007 to 2018 in order

154 abel trial, DolPHIN-2, we recruited pregnant women in South Africa and Uganda aged at least 18 years,

155 Women in the control group were unaware of the study.

156 e lowest quintile of the DEHP factor scores, women in the highest quintile had significantly lower se

157 Women in the intervention group were recruited by postal

158 Compared to women in the lowest quintile of the DEHP factor scores,

159 e assigned procedure, occurred in 29% of the women in the myomectomy group and in 24% of the women in

160 approaches to help advance the promotion of women in the sciences.

161 en in the myomectomy group and in 24% of the women in the uterine-artery embolization group.

162 es were treatment failure (the proportion of women in which surgery failed to adequately resolve midl

163 who have sex with men (MSM) and transgender women, in Bangkok, Thailand and Harlem, New York.

164 terventions for prevention interventions for women include screening, partner notification, promoting

165 Women included in the National Cancer Database with inva

166 ations included a rather small proportion of women included, the open label design, and its short dur

167 nsulin sensitive compared with control (CON) women, independent of BMI.

168 ed developmental problems in infants born to women infected with ZIKV during pregnancy(15-20), highli

169 From 2014 to 2018, we enrolled 179 pregnant women into 4 groups: "HLHS/TGA" fetuses with hypoplastic

170 n the safety and efficacy of IPT in pregnant women living with HIV (PWLHIV) are mixed.

171 We assigned women living with HIV and their child (oldest 3-8 years)

172 n education and food supplements provided to women living with HIV significantly increased weight and

173 tion to prevent recurrent HSIL after LEEP in women living with HIV.

174 Women <= 40 years of age represent a minority of patient

175 rably higher than that predicted among young women (<30 years old).

176 that treatments for alcohol use disorder in women may need to account for this sex difference.

177 During the study period, 306 pregnant women (median age 29 years, 52.9% Hispanic or Latino) wi

178 The pooled sample included 252 745 women (median age at baseline, 57 years) with 38% self-r

179 mulative risks of CRC in 50-year-old men and women (most common age of first screening), which were 0

180 Obese, black South African women (n = 45) were randomized into exercise (n = 23) or

181 advanced chondrosarcoma received ivosidenib (women, n = 8; median age, 55 years; range, 30-88 years;

182 Women of childbearing age constitute 18% of patients ope

183 redicted among men <30 years old compared to women of the same age, while women >=50 years old had a

184 l 15, 2014, and Oct 1, 2017, we enrolled 323 women, of whom 234 had perinatal HIV infection, and repo

185 onal recommendations, counseling of pregnant women on diet and physical activity recommendations, off

186 In this cross-sectional study, 60 women over 40 years of age were included.

187 SP-resistance allele frequencies in Malawian women participating in a trial comparing IPTp with SP ag

188 Of the 1624 women randomized (mean age, 30.4 years, mean body mass i

189 A significantly higher proportion of women received DNR orders (35.7% versus 32.1%, P=0.009)

190 nce in HIV-related mortality between men and women receiving antiretroviral therapy (ART) is incomple

191 We investigated 557 women, recruited between 2009 and 2014 from the UK Pregn

192 , stroke and cancer, 178,485 men and 267,202 women remained.

193 istent depression trajectories (6% and 2% of women, respectively).

194 The Young Women's Breast Cancer Study is a prospective cohort of w

195 As part of the Women's Health Initiative, randomized, placebo-controlle

196 s Initiative (WPSI), a national coalition of women's health professional organizations and patient re

197 ision medicine, which will benefit men's and women's health.

198 PCoA aneurysms diagnosed at the Brigham and Women's Hospital and Massachusetts General Hospital betw

199 any UBL intervention compared to control on women's past-year experience of physical (couples' UBL a

200 job discrimination may contribute to working women's poor sleep health over time, raising concerns ab

201 The Women's Preventive Services Initiative (WPSI), a nationa

202 fidence interval [CI]: 0.77-1.30, p = 0.973; women's UBL arm AOR = 1.11, 95% CI 0.87-1.42, p = 0.414;

203 rm AOR = 0.86, 95% CI: 0.62-1.20, p = 0.378; women's UBL arm AOR = 1.15, 95% CI: 0.89-1.50; p = 0.291

204 paraffin-embedded (FFPE, median age 67, 39% women) samples, respectively.

205 As four NIH intramural women scientists who care deeply about scientific progre

206 fe CDR of PERFORMS outliers was 7.2 per 1000 women screened and was significantly lower than other re

207 entage, cancer detection rate (CDR) per 1000 women screened, false-negative rate per 1000 women scree

208 women screened, false-negative rate per 1000 women screened, positive predictive value of recall (PPV

209 creened; 33 of 56 839) than DM (0.9 per 1000 women screened; 0.4, 1.6 per 1000 women screened; nine o

210 00 women screened; 95% CI: 0.4, 0.8 per 1000 women screened; 33 of 56 839) than DM (0.9 per 1000 wome

211 es were slightly lower for DBT (0.6 per 1000 women screened; 95% CI: 0.4, 0.8 per 1000 women screened

212 9 per 1000 women screened; 0.4, 1.6 per 1000 women screened; nine of 10 511) overall (P = .30), but t

213 Along this line, premenopausal women seem to be generally protected from obesity-induce

214 uencing of vaginal swabs from postmenopausal women self-identified as Black or White was compared usi

215 Women seronegative at their first pregnancy with a subse

216 ticity metrics were observed to be higher in women than in men and displayed moderate correlation to

217 ifferent races in Namibia (from 90% in white women to 56% in Black women) and in South Africa (from 7

218 and in South Africa (from 76% in mixed-race women to 59% in Black women), and between different coun

219 M/C were around twice as likely as non-FGM/C women to experience dyspareunia, perineal tears, prolong

220 uencing of bone biopsies from postmenopausal women to identify osteoclast-secreted factors suppressed

221 creening for anxiety in adolescent and adult women to improve detection; achieve earlier diagnosis an

222 Our study suggests that, in young women, transseptal TMVI to treat failing bioprostheses m

223 tes of scalp-detected STW in 26 patients (14 women) undergoing combined stereo-EEG/polysomnography.

224 ge, 59 years +/- 11 [standard deviation]; 35 women) underwent preventive FICS for consolidation of im

225 ocal residents (29.7%, 88.5% children, 54.4% women) underwent vision screening.

226 CHD rates in women versus men were 6.3 versus 10.7 among those withou

227 nt LVH was 3-fold higher among black men and women versus white men and women.

228 el of obesity in mice and breast tissue from women, we observed that TGFbeta1 activity is reduced in

229 In conclusion, unvaccinated pregnant women were clustered geographically and by key sociodemo

230 ion person-years of follow-up, 49,955 (2.3%) women were diagnosed with IHD.

231 Between June 1, 2007, and Aug 14, 2013, 1208 women were enrolled and randomly assigned to receive no

232 ente Southern California health care system; women were followed from January 1, 2007, to November 30

233 In total, 470,646 women were included, of whom 2113 underwent repair of a

234 h prevalent and incident CAD between men and women were investigated among 317 509 unrelated individu

235 Included women were of childbearing age (18-45 years) during the

236 Women were older (mean +/- SD age: 67.8 +/- 8.9 vs. 66.1

237 +/- 17 [standard deviation]; 18 men and two women) were included.

238 ; 22 of the 97 (mean age, 71 years +/- 6; 13 women) were positive for beta-amyloid.

239 Overall, 44 clusters (69 330 pregnant women) were randomly assigned to intervention (22 cluste

240 Women who attended religious services were less likely t

241 ommon but important complication in pregnant women who become acutely infected with Brucella melitens

242 Women who developed GDM showed increased concentrations

243 Women who did not receive chemotherapy had a more than 9

244 The data of the women who met the inclusion criteria were linked to the

245 ut consensus is lacking on the management in women who might subsequently become pregnant.

246 erative SSI was detected in 11 (1.4%) of the women who underwent caesarean operations.

247 Women who underwent FGM/C were around twice as likely as

248 Visualization was achieved in 95% (21/22) of women who used the Callascope for self-imaging.

249 biota and immune factors in pregnant African women who were HIV-uninfected (n = 314) versus HIV-infec

250 6 patients (mean age, 48 [SD, 11] years; 66% women) who underwent surgery with in-network primary sur

251 sease (CVD) is the leading cause of death in women, who have a notable increase in the risk for this

252 No increased risks were observed in women whose BMI normalized from childhood to adulthood:

253 toreduction was achieved in 290 (50%) of 576 women with a GCIG CA125 response and 30 (30%) of 101 wom

254 the serum of women with SCH when compared to women with a normal pregnancy, in the second trimester.

255 Despite worse outcomes for women with AAA, no studies have prospectively examined s

256 rmine the prevalence and phenotype of FGR in women with AMSB and test the predictive value of placent

257 dds of having A-HSIL were >6 times higher in women with anal hrHPV (adjusted odds ratio [aOR], 6.08 [

258 a parameter for future diagnostic assays for women with breast implants to distinguish seroma caused

259 We identified 2056 women with CHD (2334 pregnancies) and 1 374 982 women wi

260 nstrual period to 90 days postpartum, 56% of women with CHD had comprehensive echocardiograms and, du

261 ure the efficacy and safety of gabapentin in women with chronic pelvic pain and no obvious pelvic pat

262 result in significantly lower pain scores in women with chronic pelvic pain, and was associated with

263 ase insemination (SRI) on pregnancy rates in women with confirmed infertility or the need for semen d

264 The remaining 475 asymptomatic women with dense breasts had negative/benign DBT examina

265 Women with dense breasts have an increased lifetime risk

266 ; conversely, there was no increased risk in women with dental caries and treatment compared with tho

267 the basis of the treatment of dental caries, women with dental caries but no treatment had an increas

268 When women with dental caries were divided on the basis of th

269 sitates consideration by clinicians treating women with diverse life histories.

270 Nonpregnant women with epilepsy were enrolled as controls and had si

271 zumab can depict HER2-positive metastases in women with HER2-negative primary breast cancer.

272 abolic complications in PCOS should focus on women with high-risk features rather than all women with

273 ivariate logistic regression analysis showed women with hydrosalpinx were 2.11 times more likely to b

274 initial treatment, and hospital referral of women with hypertension.

275 Women with inherited bleeding disorders, including carri

276 Women with intrahepatic cholestasis of pregnancy (ICP),

277 and 90% by 2045, and we assumed that 50% of women with invasive cervical cancer would receive approp

278 cancer screening coverage, especially among women with limited access to health care.

279 Most women with MBC require opioid analgesia within the first

280 surgery (DPS) is an established strategy for women with newly diagnosed, advanced-stage epithelial ov

281 Women with normal cytology results and positive hrHPV re

282 GI) diet plus physical activity) in pregnant women with obesity (294 contol, 263 intervention).

283 he intervention were significantly higher in women with obesity at the begining of pregnancy (mean di

284 nt benefits of exercise training appeared in women with PCOS, including an improvement of the hyperan

285 omen with high-risk features rather than all women with PCOS.

286 Women with polycystic ovary syndrome (PCOS) have been sh

287 , P = .007), but not significantly higher in women with positive anal methylation.

288 id were significantly higher in the serum of women with SCH when compared to women with a normal preg

289 However, only 77% of women with severe preeclampsia/eclampsia received magnes

290 Women with small or large for gestational age offspring

291 used since 1991 for outpatient treatment of women with stable EP.

292 In more detail, women with the c.1592delT variant in PALB2 (242-fold enr

293 Among women with undetectable baseline anti-GBS levels, postdo

294 Immunogenicity analyses only included women with visits 28-35 days apart and infants who were

295 In addition, women with vulvodynia are more likely to report other ch

296 en with CHD (2334 pregnancies) and 1 374 982 women without (1 524 077 pregnancies).

297 th a GCIG CA125 response and 30 (30%) of 101 women without a GCIG CA125 response.

298 on, 88% under antiretroviral therapy; and 57 women without HIV from the same geographic location with

299 incidence of four or fewer cases per 100 000 women-years and ten or fewer cases per 100 000 women-yea

300 men-years and ten or fewer cases per 100 000 women-years, and an 85% or greater reduction in incidenc